Moexipril as add-on therapy to hydrochlorothiazide in moderate to severe hypertension

Cardiology (Switzerland)

Volumn 87, Issue 4, 1996, Pages 313-318

  Stimpel, Michael ^a   Koch, Brigitte ^a   Dickstein, Kenneth ^b  

^a Schwarz Pharma AG   (Germany)

^b Hjertelaget Research Foundation   (Norway)

Author keywords

Hydrochlorothiazide; Hypertension; Moexipril

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; MOEXIPRIL; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BORDERLINE HYPERTENSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HEART RATE; HUMAN; HYPERTENSION; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

EID: 0029949826     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177112     Document Type: Article

References (15)

1. White WB, Fox AAL. Stimpel M: Long-term efficacy and safety of moexipril in the treatment of hypertension. J Hum Hypertcns 1994: 8:917-921.
2. White WB. Stimpel M: Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension. J Hum Hypertens 1995;9: in press.
3. Drayer JIM. Stimpel M. Fox AAL. Weber M: The antihypertensive properties of the angiotensin converting enzyme inhibitor moexipril given alone or in combination with a low dose of a diuretic. Am J Ther 1995;2:525-531.
4. Andersson OK, Stimpel M: Fixed low-dose combinations of moexipril and hydrochlorothiazide in the treatment of hypertension. Blood Pressure, in press.
5. Wing LMH, Chalmers JP, West MJ. Bune AJC, Russell AE, Elliott JM. Morris MJ: Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: Contrasts in hypotensive interactions. J Hypertens 1987:5:603-606.
6. Kayanakis JG, Baulac L: The comparative study of oncc-daily administration of captopril 50 mg, hydrochlorothiazide 25 mg and their combination in mild to moderate hypertension. Br J Clin Pharmacol 1987;27:289S-296S.
7. Weinberger MH: Comparison of captopril and hydrochlorothiazide alone or in combination in mild to moderate hypertension. Br J Clin Pharmacol 1982; 14:127S-131S.
8. Vlasses PH. Rotmensch HH. Swanson BN, Irvin JD. Lee RB. Koplin JR. Ferguson RK: Comparative antihypertensive effects of enalapril maleate and hydrochlorothiazide, alone and in combination. J Clin Pharmacol 1983; 23:227-233.
9. Vidt DG: A controlled multiclinic study to compare the antihypertensive effects of MK-421, hydrochlorothiazide and MK-421 combined with hydrochlorothiazide in patients with mild to moderate essential hypertension. J Hypertens 1984;2:81-88.
10. Fogari R, Zoppi A, Tettamanti F, Tettamanzi D, Lusardi P. Motolese M: Evaluation by 24 h ambulatory blood pressure monitoring of efficacy of benazepril 20 mg plus hydrochlorothiazide 25 mg fixed combination as compared to captopril 25 mg plus hydrochlorothiazide 25 mg fixed combination in treating mild to moderate hypertension: A double-blind, with-in-patient, placebo-controlled study. J Car-diovasc Pharmacol 1994;24:687-693.
11. Weber MA, Drayer JIM, Rev A, Laragh JH: Disparate patterns of aldosterone response during diuretic treatment of hypertension. Ann Intern Med 1977:87:558-563.
12. Leonctti G, Tcrzoli L, Sala C: Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients. Clin Sci Mol Med 1978;55:307S-309S.
13. Ambrosioni E, Borghi C, Costa V: Captopril and hydrochlorothiazide rationale for their combination. Br J Clin Pharmacol 1987:23: 43S-50S.
14. Singer DR, Markondu ND. Fumival L, Klio-shondi L. McGregor GA: Moderate sodium restriction, angiotensin converting enzyme inhibition and thiazide diuretic in the management of essential hypertension. J Cardiovasc Pharmacol 1989; 13:S5-7.
15. McVeigh GE, Flack J, Grimm R: Goals of antihypertensive therapy. Drugs 1995;49:161-175.